PKP2 and cancer: All of the results suggest that MTs of ADPGK, PCGF6, PKP2, NUP93 and SLC22A5 can be the driver mutations controlling the cancer metastasis via affecting the EMT pathways where Snail, Claudin-1 or ZEB1 is involved.